UK markets closed
NIKKEI 225
38,837.46 -85.54 (-0.22%) HANG SENG
18,444.11 +41.11 (+0.22%) CRUDE OIL
73.34 -0.88 (-1.19%) GOLD FUTURES
2,346.70 -22.60 (-0.95%) DOW
38,711.29 +140.26 (+0.36%) Bitcoin GBP
55,084.39 +859.27 (+1.58%)
BMY Jun 2024 57.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:29AM EDT. Market open.
Loading interactive chart…
- Zacks
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
- Business Wire
Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or....
- Simply Wall St.
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...
© 2024 Yahoo. All rights reserved.